Submitted by Anonymous (not verified) on 4 July 2024 - 14:11
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised